Biosimilars

Increased simplicity, broader financial risk sharing, and an enhanced focus on patient care were among the recommendations developed by diverse stakeholders at a recent AMCP Partnership Forum focused on how to better manage the high costs of specialty medications.

Video from the December 2014 Health Plan Executive Forum featuring Steven G. Avey, RPh, MS, FAMCP, Vice President, Specialty Programs, MedImpact Healthcare Systems, Inc.; Alan M. Lotvin, MD, Executive Vice President, CVS/specialty, CVS Health; Thomas Parry, PhD, President, Integrated Benefits Institute; and Margaret Rehayem, MA, Senior Director of Strategic Intiiatives and Communications, Midwest Business Group on Health.